Studies related to Creatinine and Pterostilbene

Analysis Of Safety From A Human Clinical Trial With Pterostilbene

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 215
Gender Both Genders
Age Range 45-64
Notes for this study:
A safety study using 125mg pterostilbene twice daily (250mg each day) for 52 days in hypercholesterolemic adults failed to find any adverse effects on liver enzymes and other serum biomarkers of toxicity, suggesting its safety.